Cygnus seeks $450 million damages from Sankyo
This article was originally published in Clinica
Executive Summary
A lawsuit has been brought against Sankyo Pharma in the US and its Japanese parent by Cygnus, the manufacturer of the GlucoWatch Biographer blood glucose monitoring system that Sankyo markets and distributes.